
Join to view full profile
9200 W Wisconsin AveMilwaukee, WI 53226
Phone+1 414-805-0505
Fax+1 414-955-0231
Dr. Saber is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Wisconsin Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 2006 - 2009
Cleveland Clinic FoundationResidency, Internal Medicine, 1998 - 2001
Ain Shams University Faculty of MedicineClass of 1995
Certifications & Licensure
WI State Medical License 2006 - 2027
OH State Medical License 2000 - 2010
American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- Toolkit for multistate disease progression simulation and treatment decision-making aid.Can Xie, Ruosha Li, Wael Saber, Jorge E Cortes, Nicholas J Short
BMC Medical Research Methodology. 2026-06-22 - Clinical, Genetic, and Pathologic Variability in Myelodysplastic Syndromes and Precursor Conditions Across Race, Ethnicity, and Sex.Nancy Gillis, Christelle Colin-Leitzinger, Yi-Han Tang, Michael Otterstatter, Seth Sherman
American Journal of Hematology. 2026-06-01 - Corrigendum to: Current Activity Trends and Outcomes in Hematopoietic Cell Transplantation and Cellular Therapy - A Report from the CIBMTR, Transplantation and Cellula...Stephen R Spellman, Ke Xu, Temitope Oloyede, Kwang Woo Ahn, Othman Salim Akhtar
Transplantation and Cellular Therapy. 2026-06-01
Abstracts/Posters
- Allogeneic Hematopoietic Stem Cell Transplantation for Therapy-Related Myelodysplastic Syndromes and Acute Myeloid LeukemiaWael Saber, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Myeloablative Conditioning Is Preferred for Allogeneic Transplantation of Acute Myeloid Leukemia and Myelodysplastic Syndromes with Low/Intermediate but Not High Disea...Wael Saber, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Superior Survival with Post-Remission Pediatric-Inspired Chemotherapy Compared to Myeloablative Allogeneic Hematopoietic Cell Transplantation in Adolescents and Young ...Wael Saber, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Stem Cell Transplant in Patients with Myelodysplastic Syndromes: On Behalf of the CIBMTR Ch...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Lost to Follow-up Rates Are Higher in Pediatric Than Adult Survivors, but Not By Transplant Type: A Report from the Center for International Blood and Marrow Transplan...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
Center for International Blood & Marrow Transplant Research Celebrates 50 YearsApril 22nd, 2022
Genetic Profiling Can Guide Stem Cell Transplantation for Patients with Myelodysplastic Syndrome, Study FindsFebruary 9th, 2017
Genetic Profiling Can Guide Stem Cell Transplantation for Patients with Myelodysplastic Syndrome, Study FindsFebruary 8th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









